Macro Finance
Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline
Bloomberg Markets·July 17, 2026·1 min read
Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as soon as this quarter. The Blue Owl-backed company's IPO filing adds to the biotech pipeline, signaling renewed interest in the sector as market conditions improve for new listings.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.